Skip to main content
. 2025 Jul 21;31:260. doi: 10.1186/s10020-025-01309-z

Table 2.

Significant associations of metabolites/indicators with the respective hepatic phenotype adjusted for the full model

Metabolite or Indicator Estimate (95% CI) FDR corrected p-value Log10 p-value
Fat
 Ala 1.17 (1.08, 1.26) 0.009 2.06
 Ile 1.13 (1.05, 1.22) 0.031 1.51
 Leu 1.13 (1.05, 1.22) 0.031 1.51
 alpha.AAA 1.14 (1.05, 1.23) 0.031 1.51
 lysoPC a C17.0 0.88 (0.81, 0.95) 0.04 1.39
 PC ae C38.2 0.88 (0.82, 0.95) 0.031 1.51
 bcaa 1.13 (1.05, 1.21) 0.024 1.62
 keto_aa 1.13 (1.05, 1.21) 0.024 1.62
 PCae_PCaa 0.86 (0.79, 0.94) 0.024 1.62
Fat male
 C14 1.19 (1.08, 1.31) 0.037 1.44
 C16 1.18 (1.07, 1.3) 0.037 1.44
 Ala 1.19 (1.07, 1.31) 0.037 1.44
 alpha.AAA 1.18 (1.07, 1.31) 0.037 1.44
 PC aa C32.1 1.21 (1.08, 1.35) 0.037 1.44
 keto_aa 1.18 (1.07, 1.3) 0.027 1.57
Hepatic steatosis
 Glu 1.72 (1.24, 2.41) 0.049 1.31
 lysoPC a C17.0 0.55 (0.39, 0.76) 0.035 1.46
 PC ae C34.3 0.56 (0.4, 0.76) 0.035 1.46
 PC ae C36.2 0.59 (0.42, 0.81) 0.049 1.31
 PC ae C38.2 0.62 (0.45, 0.83) 0.049 1.31
Iron
 C0 1.02 (1.01, 1.03) 0.031 1.52
 C7.DC 1.02 (1.01, 1.03) 0.031 1.51
 Alpha.AAA 1.02 (1.01, 1.03) 0.046 1.34
 Lysopc a C20.4 1.02 (1.01, 1.03) 0.031 1.51
 PC aa C36.4 1.02 (1.01, 1.04) 0.028 1.55
 PC aa C38.4 1.03 (1.01, 1.04) 0.005 2.29
 PC aa C38.5 1.02 (1.01, 1.04) 0.018 1.75
 PC aa C40.5 1.02 (1.01, 1.04) 0.028 1.55
 PC ae C36.4 1.02 (1.01, 1.03) 0.031 1.51
 PC ae C36.5 1.02 (1.01, 1.03) 0.031 1.51
 PC ae C38.5 1.02 (1.01, 1.03) 0.046 1.34
 PC ae C38.6 1.02 (1.01, 1.03) 0.046 1.34
 SM C18.1 1.02 (1.01, 1.03) 0.04 1.4
 SM C20.2 1.02 (1.01, 1.03) 0.031 1.51
Iron male
 PC aa C34.4 1.04 (1.02, 1.05) 0.038 1.42
 SM C20.2 1.03 (1.01, 1.05) 0.038 1.42
Iron overload
 C2 1.53 (1.18, 1.98) 0.045 1.35
 C7.DC 1.46 (1.14, 1.88) 0.045 1.35
 C14.1 1.49 (1.16, 1.93) 0.045 1.35
 Alpha.AAA 1.5 (1.15, 1.96) 0.045 1.35
 PC aa C36.4 1.53 (1.18, 2.01) 0.045 1.35
 PC aa C38.4 1.5 (1.15, 1.97) 0.045 1.35
 PC aa C38.5 1.52 (1.17, 1.99) 0.045 1.35
 PC aa C38.6 1.57 (1.21, 2.05) 0.045 1.35
 PC aa C40.6 1.51 (1.17, 1.97) 0.045 1.35
 PC ae C36.5 1.46 (1.14, 1.89) 0.045 1.35
 PC ae C38.6 1.45 (1.14, 1.87) 0.045 1.35
 Bcaa 1.45 (1.12, 1.88) 0.033 1.49
 Total_AC 1.52 (1.18, 1.97) 0.02 1.71
 Total_longAC 1.44 (1.12, 1.86) 0.033 1.49
 Total_shortAC 1.56 (1.21, 2.02) 0.02 1.71
 Total_mufaAC 1.43 (1.11, 1.86) 0.033 1.49
 Total_sfaAC 1.52 (1.18, 1.98) 0.02 1.71
 Total_pufaPCax 1.5 (1.16, 1.96) 0.025 1.61
 Total_PCax 1.44 (1.1, 1.88) 0.039 1.41
 Total_PCaa 1.43 (1.09, 1.88) 0.045 1.34
GGT
 Asp 1.14 (1.07, 1.21) 0.001 2.89
 Glu 1.19 (1.11, 1.27) 0 4.04
 Phe 1.15 (1.08, 1.22) 0.001 2.96
 PC aa C38.3 1.13 (1.06, 1.22) 0.01 2
 PC aa C38.4 1.13 (1.06, 1.21) 0.007 2.19
 PC aa C40.4 1.11 (1.04, 1.19) 0.019 1.71
 PC aa C40.5 1.12 (1.05, 1.19) 0.015 1.83
 PC aa C40.6 1.11 (1.04, 1.18) 0.025 1.6
 PC ae C40.2 1.11 (1.04, 1.18) 0.015 1.83
 SM C18.0 1.16 (1.09, 1.23) 0 3.57
 SM C18.1 1.12 (1.05, 1.19) 0.013 1.9
 SM C20.2 1.11 (1.05, 1.18) 0.013 1.89
 SM C24.1 1.14 (1.07, 1.21) 0.001 2.96
 Cit_arg 0.91 (0.85, 0.97) 0.035 1.46
 Pla2 0.9 (0.84, 0.97) 0.035 1.46
 Total_SM 1.1 (1.03, 1.17) 0.035 1.46
 total_SM_nonOH 1.1 (1.03, 1.17) 0.035 1.46
GGT male
 Asp 1.14 (1.06, 1.23) 0.02 1.71
 Glu 1.19 (1.09, 1.29) 0.004 2.36
 PC aa C32.1 1.15 (1.05, 1.27) 0.043 1.37
 PC aa C36.4 1.16 (1.07, 1.27) 0.015 1.82
 PC aa C38.3 1.15 (1.05, 1.26) 0.042 1.38
 PC aa C38.4 1.19 (1.1, 1.29) 0.004 2.43
 PC aa C40.4 1.2 (1.1, 1.3) 0.004 2.43
 PC aa C40.5 1.14 (1.05, 1.24) 0.037 1.43
 SM C18.0 1.13 (1.05, 1.22) 0.036 1.45
 Total_pufaPCax 1.14 (1.05, 1.23) 0.033 1.48
 Total_PCax 1.15 (1.05, 1.25) 0.033 1.48
 Total_PCaa 1.15 (1.05, 1.25) 0.033 1.48
GGT female
 Phe 1.23 (1.1, 1.36) 0.026 1.58
 SM_PC 1.23 (1.09, 1.37) 0.02 1.69
ALT
 PC aa C40.6 1.09 (1.04, 1.14) 0.012 1.91
 PC aa C42.5 1.09 (1.04, 1.14) 0.012 1.91
 pufaPC_sfaPC 0.92 (0.88, 0.97) 0.032 1.49
AST
pufaPC_sfaPC 0.93 (0.89, 0.96) 0.005 2.32

Abbreviations CI Confidence interval